Roll over image to zoom in
Paclitaxel is an antitumor agent. Stabilizes microtubules and lowers the critical concentration for tubulin polyerization. Reversibly binds to polyerized tubulin.mInhibits protein isoprenylation and induces apoposis in PC-3 human prostatemcancer cells.
The checkpoint of mitotic spindle assembly, aberrant activation ofmcyclin-dependent kinases (CKDs) and the c-Jun N-terminal/stress activated protein
kinase (JNK/SAPK) are involved in Paclitaxel-induced apoptosis.
Store at -20℃
|Solubility||DMSO: 50 mg/mL (can be stored frozen for several months)|
|Biochem/physiol Actions||Paclitaxel is a potent anti-neoplastic and anti-mitotic taxane drug, which binds to the N-terminus of β-tubulin and and stabilizes microtubules arresting the cell cycle at the G2/M phase. The microtubule damage induces apoptosis through a JNK-dependent pathway followed by a JNK-independent pathway, perhaps related to the activation of protein kinase A (PKA) or of Raf-1 kinase, resulting in phosphorylation of Bcl-2. A major metabolite via CYP2CB is 6α-hydroxypaclitaxel (6α-OHP).|
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.